{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Villers A"],"funding":["NCI NIH HHS"],"pagination":["333-342"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9084627"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["72(3)"],"pubmed_abstract":["<h4>Background</h4>Focal ablative therapy may be a suboptimal option for anterior prostate cancers (APCs) reaching the prostate apex due to concerns for thermal injury to the external sphincter.<h4>Objective</h4>To explore the technical feasibility of anterior partial prostatectomy (APP) for isolated APCs detected by magnetic resonance imaging (MRI), and to report short-term oncologic and functional outcomes.<h4>Design, setting, and participants</h4>Following institutional review board approval, over an 8-yr period (2008-2015) 17 consenting patients were enrolled in a prospective single-arm single-center Innovation, Development, Exploration, Assessment, Long-term (IDEAL) phase 2a study. Inclusion criteria comprised preurethral, low- to intermediate-risk APC diagnosed by MRI, and targeted b"],"journal":["European urology"],"pubmed_title":["Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes."],"pmcid":["PMC9084627"],"funding_grant_id":["P30 CA014089"],"pubmed_authors":["Puech P","Gill IS","Leroy X","Flamand V","Crouzet S","Chopra S","Lemaitre L","Ouzzane A","Haber GP","Villers A","Desai MM"],"additional_accession":[]},"is_claimable":false,"name":"Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.","description":"<h4>Background</h4>Focal ablative therapy may be a suboptimal option for anterior prostate cancers (APCs) reaching the prostate apex due to concerns for thermal injury to the external sphincter.<h4>Objective</h4>To explore the technical feasibility of anterior partial prostatectomy (APP) for isolated APCs detected by magnetic resonance imaging (MRI), and to report short-term oncologic and functional outcomes.<h4>Design, setting, and participants</h4>Following institutional review board approval, over an 8-yr period (2008-2015) 17 consenting patients were enrolled in a prospective single-arm single-center Innovation, Development, Exploration, Assessment, Long-term (IDEAL) phase 2a study. Inclusion criteria comprised preurethral, low- to intermediate-risk APC diagnosed by MRI, and targeted b","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Sep","modification":"2025-04-05T14:42:45.105Z","creation":"2025-04-05T14:42:45.105Z"},"accession":"S-EPMC9084627","cross_references":{"pubmed":["27613061"],"doi":["10.1016/j.eururo.2016.08.057"]}}